BLACK RICHARD B
Known title: DirectorCIK: 0001199697
Associated companies
Transaction History
| AAOI | ▼ Sell | Gift | 2,200 | $0 | 9/15/2026 | View on chart |
| AAOI | ▲ Buy | Grant | 1,166 | $0 | 6/9/2026 | View on chart |
| AAOI | ▼ Sell | Open Market | 3,231 | $307K | 3/5/2026 | View on chart |
| AAOI | ▼ Sell | Gift | 600 | $0 | 11/26/2025 | View on chart |
| AAOI | ▼ Sell | Gift | 1,900 | $0 | 8/22/2025 | View on chart |
| AAOI | ▲ Buy | Grant | 12,281 | $0 | 6/13/2025 | View on chart |
| AAOI | ▼ Sell | Open Market | 10,000 | $290K | 1/15/2025 | View on chart |
| AAOI | ▼ Sell | Open Market | 10,000 | $353K | 12/16/2024 | View on chart |
| AAOI | ▼ Sell | Open Market | 8,162 | $303K | 11/26/2024 | View on chart |
| AAOI | ▼ Sell | Open Market | 10,000 | $275K | 11/15/2024 | View on chart |
| AAOI | ▲ Buy | Grant | 16,483 | $0 | 6/21/2024 | View on chart |
| AAOI | ▲ Buy | Grant | 40,925 | $0 | 6/26/2023 | View on chart |
| AAOI | ▲ Buy | Grant | 52,995 | $0 | 6/27/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Applied Optoelectronics shifts focus to AI‑driven DOCSIS network intelligence
Applied Optoelectronics is shifting its focus toward AI‑driven DOCSIS network intelligence, a move highlighted in recent coverage. The company’s shares have surged 205% this year and climbed 8% on the day, joining a broader rally that lifted several tech names. Analysts note the stock remains volatile, with a 52‑week range of $18.50 to $233.67, and the firm still faces significant tests ahead.
Applied Optoelectronics shifts focus to AI‑driven DOCSIS network intelligence. Applied Optoelectronics is shifting its focus toward AI‑driven DOCSIS network intelligence, a move highlighted in recent coverage. The company’s shares have surged 205% this year and climbed 8% on the day, joining a broader rally that lifted several tech names. Analysts note the stock remains volatile, with a 52‑week range of $18.50 to $233.67, and the firm still faces significant tests ahead.